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Summary
Background: Pathogens are frequently implicated in equine respiratory disease. In Ethiopia, respiratory disease is a frequent cause for presentation at
veterinary clinics and a priority concern for users of working horses. However, there is little existing literature on possible aetiologies.
Objectives: Determine prevalence of respiratory signs and exposure to major respiratory pathogens through a serological survey.
Study design: Cross-sectional.
Methods: Systematically selected horses from 19 sites in central Ethiopia were examined clinically and sampled once (August-December 2013). A face-
to-face interview collected data on horses’ management and history. Serological testing targeted equine influenza virus (EIV), equine herpesviruses-1
(EHV-1) and -4 (EHV-4), equine rhinitis viruses A (ERAV) and B (ERBV), equine arteritis virus (EAV) and Streptococcus equi subspecies equi (S. equi).
Results: Owners reported a recent history of coughing in 38% of horses and nasal discharge in 7%. No animals were observed coughing during
examination but 6% had a nasal discharge. Antibodies towards S. equi, were most prevalent (8%, 33/350). Antibodies to EAV were confirmed in one
animal (0.3%). Low antibody titres to EHV-1/4 and ERA/BV suggested prior exposure but antibodies to EIV were not detected. Multivariable, multilevel
logistic regression analysis for risk factors associated with S. equi serostatus showed higher odds of seropositivity in younger animals and those
working less frequently.
Main limitations: A single serological sample cannot describe dynamic changes in antibodies. Sampling horses at the place of work may result in
healthy-worker bias.
Conclusions: S. equi may be endemic in this population and contributing, in part, to the occurrence of respiratory disease. Low prevalence of
antibodies to viruses, with the exception of EIV, indicates these pathogens are present, but unlikely a predominant cause of respiratory signs and
noninfectious causes of disease should also be investigated. Working horses in this region would be vulnerable to incursion of equine influenza.
Keywords: horse; strangles; Streptococcus equi; prevalence; serology; Africa; ELISA
Introduction
Ethiopia has Africa’s largest equid population which is continuing to grow
[1]. The 2 million working horses are used in urban and rural environments
to pull cart-taxis as ‘gharry’ horses or ridden as saddle horses. They
transport people, produce, water and building materials and are an
important source of income for whole families [2].
Respiratory disease is recognised as impacting work ability in equines
worldwide [3–5], with coughing and nasal discharge, being a priority
concern for users of working horses in Ethiopia [2,5,6]. A recent
assessment of working equid health [7] identified a poorly defined
respiratory syndrome as one of three syndromes with high prevalence and
morbidity and that investigation to determine the role of infectious agents
is critical. In addition, respiratory conditions identified at SPANA (Society
for the Protection of Animals Abroad) veterinary clinics over a 5-year
period accounted for up to 15% of all horses seen, including those
presented for routine veterinary interventions such as vaccination or
deworming (2007–2012; unpublished data). Despite this, there is little
literature on the possible aetiology of respiratory disease in Ethiopia or
other countries with a large working equid population. Elsewhere infectious
causes of respiratory disease are common [8,9] but diagnostic capabilities
in Ethiopia mean prevalence data for major respiratory pathogens are
lacking. As such, it is difficult to speculate as to the aetiology of disease or
provide evidence-based recommendations for treatments or preventive
measures.
The objectives of this study were to determine the prevalence of
respiratory signs in Ethiopian working horses and seroprevalence to major
respiratory pathogens based on serological assays. Major respiratory
pathogens considered were: equine influenza virus (EIV), equine
herpesviruses-1 (EHV-1) and -4 (EHV-4), equine rhinitis viruses A (ERAV) and
B (ERBV), equine arteritis virus (EAV) and the bacterial pathogen S. equi.
Materials and methods
A cross-sectional study was conducted across 19 sites in central Ethiopia
(August–December 2013). Sites included rural and urban locations with
substantial horse populations across lowland (<1500 m) to highland
(>2300 m) regions representative of the region. Informed consent was
sought verbally from owners/drivers.
As literature for respiratory pathogen seroprevalence in other countries
vary widely (1–95%) [8–12], a 50% prevalence was used to estimate sample
size with an absolute precision of 10% and 95% confidence intervals [13].
This was then adjusted for clustering of horses within towns according to
Dohoo et al. [14]. There was no existing literature on intra-cluster
correlation (ICC) for respiratory infections in Ethiopian horse populations so
a best estimate of 0.1 was used based on ICC for infectious diseases in
other species [15,16]. A cluster size of 18 provided a final sample size of
262 animals across 15 towns.
Horses, with their owner or driver, were selected from a focal point in
the town such as a cart-taxi waiting area or parking area at a market. A
systematic sampling strategy was employed where every other horse was
selected from a dynamic queue or parking place.
A brief questionnaire underwent reverse translation before being
administered individually by an Ethiopian research assistant in either of two
regional languages (Amharic or Afan Oromo). This included horse details,
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husbandry practices and history of respiratory signs in the preceding
30 days (Supplementary Item 1). Any history of respiratory disease was
described by participants in their own words first, and if nasal discharge
(ND) was volunteered, an illustrated chart developed during a previous
participatory study [17] was used (Supplementary Item 2).
A brief but systematic clinical examination included jugular blood
samples, an estimation of age based on dentition, body condition score
(BCS, scale 0–5) [18], description of ND and breathing characteristics,
thoracic auscultation, cranial lymph node assessment, and rectal
temperature. Also recorded was information on harness fit where this was
a possible cause for respiratory obstruction.
Clinical samples
Serum was heat treated at 56°C for 30 min, then stored at 4°C until
transported to the UK and stored at 20°C. Manual packed cell volume
(PCV) and total plasma protein (TPP) were measured.
All serum samples were processed and analysed by the first author at
the Animal Health Trust, Newmarket, UK (AHT). Serological tests were run
in accordance with the laboratory’s Standard Operating Procedures, with
the exception of the commercially available influenza kit, which was
conducted according to the manufacturer’s guidelinesa. All samples were
run in duplicate with positive and negative controls on each plate. Table 1
summarises the serological methods used. ELISA optical density (OD)
values were considered relative to both positive and negative controls.
Samples achieving or exceeding the screening threshold OD in the EAV
ELISA were subject to virus neutralisation test (VN) to identify true EAV
seropositive results [19]. Controls for cross-reaction between test antigens
and sample antibodies to all four viruses (EHV-1, EHV-4, ERAV and ERBV)
on complement fixation tests were in place and any anticomplementary
activity of serum samples considered when reporting final antibody titres.
As no equine influenza strain information exists for Ethiopia, serology for
EIV used a multispecies Influenza A competitive ELISAa [20,21].
Manufacturer’s guidelines were adapted with an initial sample/buffer
mixing step and a strong and weak positive control from AHT library serum
(H7N7 Prague/56, H3N8 Miami/63, H3N8 Newmarket/2/93). Any samples
showing percentage inhibition <100% were subsequently tested using the
OIE gold standard haemagglutination inhibition (HI) for known equine
influenza strains.
Data analysis
Due to the clustering of animals by sampling locations in a town,
prevalence for serostatus to all pathogens was adjusted for clustering with
estimates derived from intercept-only models with sample location
included as a random effect. Confidence intervals (95%) were calculated as
a function of the standard error.
Horse- and owner-level associations with serostatus were investigated.
Associations with S. equi serostatus were examined using univariable and
mulitvariable multilevel logistic regression models with a binomial
distribution and logit link function in which sampling location (town) was
included as a random effect using R. Serological test results were
considered as a binary outcome (seropositive/seronegative) (Table 2).
Continuous variables were assessed for linearity using generalised additive
models (GAM) and then analysed using univariable logistic regression.
Correlation between variables to be included in the multivariable logisitic
regression model was assessed, with exclusion of correlated variables
(correlation coefficient >0.7) with the greater P-value. In building the final
model all explanatory variables with a P-value <0.25 from univariable
analysis were initially included. A backwards-stepwise approach then
eliminated each variable manually until only those with a significant
likelihood ratio (LRT) P-value (≤0.05) remained, or where their removal
substantially (>25%) altered coefficients of other variables indicating
confounding. Each eliminated variable was individually added back into the
multivariable model and the final model assessed for two-way interactions
to further establish best fit.
The intra-class correlation coefficient (ICC) for within-site clustering was
estimated using the latent-variable method [22], which assumes variation at
the individual level is approximately equal to (p2)/3.
Results
A total of 19 study locations (Fig 1) and 395 participants were selected,
with 350 horses undergoing both clinical examination and blood sampling.
Behaviour prohibited examination and blood sampling in 45 horses. The
vast majority of participants (97%) owned the animal examined, with
duration of ownership ranging from 2 days to 15 years (median 1.0 years,
interquartile range (IQR) 0.5–3.0 years). Of these, over half (55%) owned
only the horse examined whereas 39% owned a second horse. The
majority (84%) were driven as ‘gharry’ carthorses, most citing their cart as
their main source of income (83%). Median distance travelled to sample site
was 2 km (IQR 1–5 km), but nearly 10% travelled over 10 km. Uptake of
free vaccination for African Horse Sickness was approximately 30%, and
owners reported that 43% of animals had received an antiparasitic
treatment in the last 12 months.
The vast majority (95%) of animals examined were male, two-thirds (70%)
of which were gelded. Estimates of age from dentition suggest a median of
12 years (IQR 9–15 years), but animals ranged from 9 months to over
20 years old.
Most horses (82%) were in moderate (BCS 2/5) or good body condition
(BCS 3/5), but nearly a fifth (18%) were in poor or very poor body condition
(BCS 0–1/5). Owners reported a recent (preceding 30 days) history of
coughing in 38% of cases (n = 134), nasal discharge in 7% (n = 25: 15
serous, 8 purulent, 2 bloody), while 3% (n = 11) reported recently suffering
other breathing problems. No animals were noted to cough during clinical
examination but 6% had an observed nasal discharge (n = 21: 10 serous, 9
mucopurulent, one bloody, one food material). Five animals showed
enlarged submandibular lymph nodes but not in combination with nasal
discharge or pyrexia. Increased lung sounds on auscultation were heard in
5% of horses. Median respiration rate (RR) was 40 breaths/min (IQR 32–48)
and median heart rate (HR) was 48 beats/min (IQR 44–52). Median PCV was
34% (IQR 30–37) and TPP was 80 g/L (IQR 74–86). Due to the potential
effects of recent exercise, values for animals resting for a minimum of
20 min prior to examination (n = 151) were also assessed but median
values were not altered for this subset. Measurements for HR, RR, PCV and
TPP were compared with ‘normal’ reference intervals (Fig 2) commonly
used in the UK [23] and, where available, to working equid reference
intervals [24]. A large number of Ethiopian horses had parameters that
TABLE 1: Serological tests used in this study and information on previously published methods, test sensitivity and specificity and criteria
used for positive cutoff
Pathogen Serological test Published methods Sensitivity/Specificity Criteria for positive cutoff
S. equi Dual antigen A & C ELISA [25] 93.3%/99.3% Positive: OD ≥0.5
Equine arteritis virus ELISA [39] 96.8%/95.6% OD ≥ 0.5
Virus neutralisation [40] Neutralisation ≥75%
Equine herpesvirus (1/4) Complement fixation [35] Reciprocal dilution titre ≥1:80
Equine rhinitis virus (A/B) Complement fixation [35] Reciprocal dilution titre ≥1:80
Equine influenza virus ELISA [20] 95.3%/79–99% Percentage inhibition ≥55%
Haemagglutination inhibition [41] Reciprocal dilution titre ≥1:32
OD, optical density; ELISA, enzyme-linked immunosorbant assay; OIE, World Organisation for animal health, equine influenza virus strains for
haemagglutination inhibition: H7N7 Prague/56, H3N8 Miami/63 and H3N8 Newmarket/2/93.
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were in excess of normal UK limits, particularly for RR (150/151 RR>15) and
TPP (119/151, TPP>73).
Serological results
The results of serological testing of all samples are presented in Table 2.
Antibodies to S. equi were the most prevalent (8%). Previous exposure to
equine arteritis virus was confirmed by VN in one animal (0.3%). Presence
of low antibody titres in half of those animals tested by CFT provided
evidence of prior exposure to EHV-1/-4 or ERA/BV in half of those tested
but was not indicative of response to recent infection (Supplementary Item
3). Antibodies to EIV were not detected. S. equi prevalence by sampling
location is shown in Figure 1 and Supplementary Item 4.
Horse- and owner-level associations with S. equi
seropositve horses
The results of univariable logistic regression analysis of clinical examination
findings and questionnaire responses with S. equi serostatus, adjusted for
clustering within site, are presented in Supplementary Items 5–7. There
were no significant associations between serostatus for S. equi and clinical
examination findings (Supplementary Item 5).
To evaluate the shape of the relationship between continuous
explanatory variables and the outcome, generalised additive models (GAM)
were used. Age and number of days worked were linearly associated with
the outcome. The final multilevel model showed that age of horse and
number of days worked per week were significantly linearly associated
with S. equi seropositive status (Table 3). The odds of seropositive status
decreased by 0.9 (95% CI 0.81–0.96) for each year increase of a horse’s
age. Similarly, the odds of seropositive status decreased by 0.7 (95% CI
0.49–0.98) for each additional day worked per week, no significant
interactions between variables remaining in the final model were detected.
From the final model, the ICC for S. equi within sampling location was
estimated to be zero.
Discussion
This is the most comprehensive study into the frequency of signs and
pathogens associated with infectious respiratory disease in the working
horses of Ethiopia. Results demonstrated an 8% seroprevalence to S. equi,
the causative agent of strangles, similar to the prevalence reported in one
other African study in Lesotho (10%) [10] that used similar diagnostic
techniques (dual antigen ELISA) [25] and in Saudi Arabia (12%) [26]. A
positive ELISA result suggests prior exposure to S. equi causing active
infection, persistent colonisation with carrier status, or immunity following
a full recovery [27,28].
There was no association between S. equi serostatus and clinical
examination findings or a history of respiratory signs reported by owners.
One potential explanation, as in other endemic areas [28], is that a milder,
atypical form of the disease exists, with little or no nasal discharge and no
discharging lymph nodes [29,30]. This presentation following infection can
be linked with challenge dose (A. Waller, personal communication),
previous exposure to S. equi or S. zooepidemicus, or host-factors such as
age or immunocompetence [28]. The lack of association of serostatus with
clinically apparent disease may also be a consequence of the cross-
sectional sero-epidemiological study design, as detectable antibody levels
arise only 2 weeks after infection and can persist for weeks or several
months following resolution of signs [25]. A second serum sample would
normally be recommended to assess the dynamic nature of the titre but
was not possible in this study design.
From analysis it was apparent that those animals working more
frequently (greater number of days per week) might be at lower odds of
being seropositive for S. equi. Rather than hypothesising a causal
relationship leading to disease, this may be due to the effect of
convalescent animals working less frequently, and as such it is difficult to
establish the impact of work on serological status. There may also be some
bias introduced by sampling at the horses’ place of work, leading to an
over-representation of those animals able to work more frequently and
thus missing those subjects absent from work due to sickness (healthy-
worker bias). This may have led to an underestimation of disease
prevalence in this study.
In this study, younger horses may be at greater odds of being
seropositive to S. equi than older animals. Younger animals were perhaps
more frequently exposed to infection, or older horses may have lower or
shorter duration of antibody levels. The latter would be contrary to the
expected response in immune animals following re-exposure, where a
greater, more rapid anamnestic B cell-mediated immune response is
normally mounted and is expected to last longer. Infection with S. equi
also stimulates a mucosal response in the nasopharynx, but it is unclear if
the organism could be cleared without a systemically detectable rise in
antibodies [31]. Thus, it could be proposed that significant differences
in serostatus of horses of different ages do not represent a difference in
exposure to the pathogen, but in host-pathogen interactions. It is also
possible that age could be a proxy for another, unmeasured exposure risk.
Neither identified risk-factor presents an easily modifiable solution that
could be recommended from this work.
Clustering of S. equi serostatus was very low, however the sampling
locations had large equine populations and some participants travelled
long distances to the sample site, thus a low ICC is plausible.
Viral pathogens are frequently implicated in respiratory disease [32] but
seroprevalence in this population was low. Findings are in contrast to
earlier studies reporting the prevalence of antibodies to EHV-1 and -4 in
Ethiopian horses of 14–21% and 88–96% respectively [12,33]. However,
these previous studies both used ELISA serological tests, and show similar
EHV-1 and -4 detection rates to studies using the same methodologies
elsewhere [34]. Thus, this discrepancy is likely due to use of complement
fixation techniques in this study, with results possibly indicative of more
recent infection where others had detected longer lasting virus neutralising
antibodies [35]. This apparently low rate of detection in Ethiopia compared
with surveillance studies for EHV elsewhere may also, in part, be due to
differences in sampling between studies. Prevalence of herpesvirus in
other studies is often from animals either presenting with signs of
TABLE 2: Serology results, adjusted for clustering within site, for respiratory pathogens in working horses in Ethiopia (n = 350). Virus
neutralisation testing for EAV of those positive on ELISA only (n = 17), Haemagglutination Inhibition testing only for EIV of potentially
disputable negative ELISA results only (n = 20)
Pathogen Test (cut off) Seropositive (n) Prevalence (%) Lower 95% CI Upper 95% CI
S. equi ELISA (≥0.5) 33 8.0 4.7 13.1
EAV ELISA (≥0.5) 17 4.2 2.1 8.3
Virus neutralisation (≥75%) 1 0.3 <0.01 2.1
EIV ELISA (≥55%) 1 0.3 <0.01 2.1
Haemagglutination inhibition (≥1:32) 0 0.0
EHV-1 Complement fixation (≥1:80) 0 0.0
EHV-4 Complement fixation (≥1:80) 0 0.0
ERAV Complement fixation (≥1:80) 0 0.0
ERBV Complement fixation (≥1:80) 0 0.0
EAV, equine arteritis virus; EIV, equine influenza virus (H7N7 Prague/56, H3N8 Miami/63 and H3N8 Newmarket/2/93); EHV, equine herpesvirus, ERA/BV,
equine rhinitis virus; CI, confidence intervals.
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respiratory disease [8,9], or present at certain events (e.g. sales), more
often attended by young na€ıve horses [11,36].
Detection of equine arteritis virus was rare and therefore is unlikely to be
a major contributor to respiratory disease in this population. However, EAV
is an important cause of reproductive losses causing abortion, and the
single confirmed positive animal in this survey was a breeding mare. It is
difficult to speculate as to the significance of this finding as VN antibodies
to EAV can last for years [36]. Mares were underrepresented in the sample,
and it appears that mares are more commonly found in breeding areas
located in the highlands that may have a different exposure rate to EAV.
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Fig 1: Map showing sampling sites and seroprevalence for S. equi. Red points indicate a site where no seropositive horses were detected. Blue points are proportional in
size to the prevalence of S. equi positive animals detected at each location.
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The single borderline positive result on ELISA testing for influenza
antibodies was neither repeatable, nor confirmed by HI test. This may
potentially indicate a novel strain/clade of influenza not targeted in HI
testing (H3N8 nor H7N7), or it is more likely a false positive test result due
to the detection limit of the test. The lack of circulating antibodies to EIV
makes this population na€ıve and potentially vulnerable to outbreaks of
equine influenza. There are few disease control measures in place in
Ethiopia to mitigate this risk, but in the author’s experience, the low value
of horses and difficulty of transport currently means there is limited long-
distance or international horse movement, which may keep any risk of
introduction low.
Coughing and abnormalities on respiratory auscultation were relatively
rare on clinical examination in this study. This may be a limitation of the
examination, due to it being performed rapidly under roadside conditions,
to allow owners to return to work as soon as possible. In contrast, owner
reporting of recent respiratory signs was more common and in agreement
with findings from participatory studies [5,6]. There was some
disagreement between veterinary clinical examination findings and owner
questionnaire responses. For example, 21 (6%) animals were identified with
a nasal discharge during examination, but only 6 of these were reported by
participants in their questionnaire responses. Literature on the reliability of
owner-reporting of clinical signs suggests it is a fairly successful tool for
chronic respiratory disease [37] but reporting of more general health
problems by owners has been less useful [10,38]. To minimise bias arising
from inter-observer variation in subjective assessments, all examinations
were carried out by the first author.
Analysis of some clinical parameters relied on established limits for
normal animals; for example RR, HR, PCV and TPP [23,24]. However, a
greater proportion of horses than expected fell outside these limits, with
high RR and increased TPP levels in over three-quarters of horses in this
study. Interpretation of these values without further biochemical analysis is
difficult. To avoid the impact of using these potentially inappropriate limits
for normal cut-offs, parameters were assessed as both continuous and
categorical variables. The apparent deviation of this population from
previously published ranges for other populations may suggest the need
for further investigation.
Limitations of using a cross-sectional study design with serological
indication of pathogen-exposure are that prevalence relates to both the
frequency of infection but also the duration of the antibody response. The
use of a single measure of antibody may over-represent diseases with a
longer duration of raised antibody, chronic disease or persistently infected
carrier states. It also fails to account for infection in immunocompromised
animals with a reduced antibody response, nor does it capture any
seasonal pattern to disease, outbreaks of infection or reactivation of latent
infections. An area not fully addressed in this current study was the
identification of, and role played by, S. equi carrier animals as a source of
new infections. This was partly due to the limited diagnostic capabilities
in-country, where the gold standard testing of guttural pouch lavage was
not readily available. While this study was able to give some indication of
co-infections of respiratory pathogens, it was not possible to look at a
range of infections potentially affecting overall health. This would be an
area of interest for future work.
The results of this study highlight the presence of infectious causes of
respiratory disease in the working horses in central Ethiopia. It appears
10 30 50
Respiratory rate (breaths/min) Heart rate (beats/min)
Packed cell volume (%) Total plasma protein (g/L)
70 30 5040 7060
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Fig 2: Smoothed distribution curves of clinical parameters for rested horses (n = 151), shown with comparison to published reference intervals for other populations.
Upper and lower limits for normal for a UK horse population [23] (green). Comparison of haematological values to those from another working equid population in
Pakistan (blue dashes) [24]. 2.5 and 97.5% percentiles for this study population (grey dashes).
TABLE 3: Multivariable, multilevel logistic regression model of
factors associated with S. equi seropositive working horses in
Ethiopia across 19 sites adjusted for within-site clustering
(n = 350)
Variable Coefficient
Odds
ratio
Lower
95% CI
Upper
95% CI
LRT
P-value
Dental age (per year
increase in age)
0.12 0.9 0.81 0.96 <0.01
Days worked per
week (per day
increase in time
worked)
0.36 0.7 0.49 0.98 0.04
LRT, likelihood ratio test.
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that S. equi may be endemic in this working equid population, however
further studies to assess the role of other infections and noninfectious
respiratory disease would help to build a more complete picture of disease
in this population.
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Supporting Information
Additional Supporting Information may be found in the online version
of this article at the publisher’s website:
Supplementary Item 1: Participant questionnaire (English Language
version).
Supplementary Item 2: Nasal discharge chart used to aid participants’
description of respiratory signs seen in their working horses: 1-none, 2-
serous, 3-mild mucopurulent, 4-unilateral mucopurulent, 5-severe
mucopurulent, 6-epistaxis.
Supplementary Item 3: Antibody titre results from complement fixation
for EHV-1, EHV-4, ERAV and ERBV. Anti-complementary activity was
included and low final titres indicate historical exposure but not recent
infection.
Supplementary Item 4: S. equi serology results (positive ≥0.5 and
borderline 0.3–0.4) in working horses in Ethiopia (n = 350) by sampling
location (in order of elevation from high to low). Possible co-infection is
indicated by number of horses seropositive to S. equi and with low
antibody titres to viral pathogens (EVA n = 0, EHV-1 n = 14, EHV-4
n = 16, ERAV n = 6, ERBV n = 10, EIV n = 0).
Supplementary Item 5: Univariable multilevel logistic regression
analysis of clinical examination and haematological variables associated
with serostatus for S. equi in working equids (n = 350). Odds ratios and
confidence intervals are adjusted for within-site clustering.
Supplementary Item 6: Univariable, multilevel logistic regression model
of continuous risk factors and clinical parameters associated with S. equi
seropositive working equids across 19 sites in Ethiopia, adjusted for
within-site clustering (n = 350).
Supplementary Item 7: Univariable, multilevel logistic regression model
of risk factors associated with S. equi seropositive working equids across
19 sites in Ethiopia, adjusted for within-site clustering (n = 350).
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